The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities.EBI
University of Southampton
Development of rationally designed DNA N6 adenine methyltransferase inhibitors.EBI
University of Southampton
Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method.EBI
University of Southampton
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors.EBI
University of Southampton
Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).EBI
University of Southampton
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale.EBI
University of Southampton
Systematic Investigation of Lipophilicity Modulation by Aliphatic Fluorination Motifs.EBI
University of Southampton
Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors.EBI
University of Southampton
Total Synthesis of Xanthoangelol B and Its Various Fragments: Toward Inhibition of Virulence Factor Production of Staphylococcus aureus.EBI
University of Southampton
A genetically selected cyclic peptide inhibitor of BCL6 homodimerization.EBI
University of Southampton
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines.EBI
University of Southampton
Methods for treating depressive symptomsBDB
Alkermes Pharma Ireland
Neprilysin inhibitorsBDB
Theravence Biopharma R&D Ip